Crinetics Pharmaceuticals Inc buy BiotechBee
Start price
03.09.23
/
60%
€16.20
Target price
30.11.25
€20.00
Performance (%)
75.31%
End price
01.10.23
€28.40
Summary
This prediction ended on 01.10.23 with a price of €28.40. With a performance of 75.31% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Crinetics Pharmaceuticals Inc where he still thinks Crinetics Pharmaceuticals Inc is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Crinetics Pharmaceuticals Inc | 1.754% | 1.754% |
iShares Core DAX® | -0.268% | 5.471% |
iShares Nasdaq 100 | 1.854% | 7.851% |
iShares Nikkei 225® | 0.284% | 1.729% |
iShares S&P 500 | 1.178% | 5.269% |
According to BiotechBee what are the pros and cons of Crinetics Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Buy mit Kursziel 20,0
In the thread Trading Crinetics Pharmaceuticals Inc
Buy beendet
Current prediction by BiotechBee for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€30.80
10.12.23
10.12.23
€45.00
30.06.25
30.06.25
52.60%
15.05.24
15.05.24
Could be very worthwhile Investment >20% year